Background: Acute respiratory failure (ARF) occurring during idiopathic pulmonary fibrosis (IPF) is associated with a poor prognosis. In this subset of individuals, mechanical ventilation (MV) may be required. Objectives: We analysed the characteristics of a group of IPF patients undergoing MV for ARF in order to give some indications on the supposed prognosis. Methods: Hospital records of 34 consecutive patients with IPF, who underwent MV for ARF, were retrospectively examined. Demographic data, time from diagnosis, gas exchange, Acute Physiology and Chronic Health Evaluation (APACHE) II score, ARF causes and MV failure were recorded. Results: Fifteen subjects (group A) underwent invasive MV and 19 patients (group B) non-invasive ventilation (NIV). The 2 groups were different for disease severity (APACHE II score 24.2 ± 6 vs. 19.5 ± 5.9; p = 0.01). Both ventilatory strategies temporarily increased PaO2/FiO2 as compared with spontaneous breathing (group A: 148.5 ± 52 vs. 99 ± 39, p = 0.0004; group B: 134 ± 36 vs. 89 ± 26, p = 0.0004). NIV reduced the respiratory rate (26 ± 7 vs. 36 ± 9 with spontaneous breathing; p = 0.002). Duration of MV correlated with the time of evolution of IPF (r = 0.45; p = 0.018). The in-hospital mortality rate was 85% (100% for invasive MV, 74% for NIV). Four of the 5 survivors died within 6 months from hospital discharge (range 2–6 months). Conclusions: MV does not appear to have a significant impact on the survival of patients with end-stage IPF. NIV may be useful for compassionate use, providing relief from dyspnoea and avoiding aggressive approaches.

Journal Section:
Editor's choice
Keywords:
Acute respiratory failure, Idiopathic pulmonary fibrosis, Invasive mechanical ventilation, Non-invasive mechanical ventilation
1.
Panos RJ, Mortenson RL, Niccoli SA, King TE Jr: Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990;88:396–404.
2.
Blivet S, Philit F, Sab JM, Langevin B, Paret M, Guerin C, Robert D: Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001;120:209–212.
3.
Stern JB, Mal H, Groussard O, Brugière O, Marceau A, Jebrak G, Fournier M: Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest 2001;120:213–219.
4.
Fumeaux T, Rothmeier C, Jolliet P: Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. Intensive Care Med 2001;27:1868–1874.
5.
Saydain G, Islam A, Afessa B, Ryu JH, Scott JP, Peters SG: Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 2002;166:839–842.
6.
Al-Hameed FM, Sharma S: Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can Respir J 2004;11:117–122.
7.
Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A: Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit. A study of 20 cases. Med Clin (Barc) 2003;121:63–67.
8.
Suh GY, Kang EH, Chung MP, Lee KS, Han J, Kitaichi M, Kwon OJ: Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest 2006;129:753–761.
9.
Estenssoro E, Gonzàles F, Laffaire E, Canales H, Sàenz G, Reina R, Dubin A: Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest 2005;127:598–603.
10.
American Thoracic Society (ATS) and European Respiratory Society (ERS): Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000;161:646–664.
11.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbad WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–1655.
12.
Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;ii:81–84.
13.
International Consensus Conference in Intensive Care Medicine: non-invasive positive-pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 2001;163:283–291.
14.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–829.
15.
Meduri GU, Conoscenti CC, Menashe P, Nair S: Noninvasive face mask ventilation in patients with acute respiratory failure. Chest 1989;95:865–870.
16.
Suter PM, Fairley B, Isemberg MD: Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med 1975;292:284–289.
17.
Sassoon CS, Giron AE, Ely EA, Light RW: Inspiratory work of breathing on flow-by and demand-flow continuous positive airway pressure. Crit Care Med 1989;17:1108–1114.
18.
Nava S, Rubini F: Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis. Thorax 1999;54:390–395.
19.
Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS: Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997;99:944–952.
20.
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301–1308.
21.
Fernandez-Perez ER, Ylmaz M, Jenad H, Daniels CE, Ryu JH, Hubmayr RD, Gajic O: Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 2008;133:1113–1119.
22.
Peter JV, Moran JL, Phillips-Hughes J, Warn D: Non-invasive ventilation in acute respiratory failure – a meta-analysis update. Crit Care Med 2002;30:555–562.
23.
Valipur A, Cozzarini W, Burghuber OC: Non-invasive pressure support ventilation in patients with respiratory failure due to severe acute cardiogenic pulmonary edema. Respiration 2004;71:144–151.
24.
Piastra M, Antonelli M, Caresta E, Chiaretti A, Polidori G, Conti G: Noninvasive ventilation in childhood acute neuromuscular respiratory failure: a pilot study. Respiration 2006;73:791–798.
25.
Antonelli M, Pennisi MA, Montini L: Clinical review: non-invasive ventilation in the clinical setting – experience from the past 10 years. Crit Care 2005;9:98–103.
26.
Antonelli M, Conti G, Rocco M, Bufi M, De Blasi RA, Vivino G, Gasparetto A, Meduri GU: A comparison of non-invasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998;339:429–435.
27.
Chiumello D, Pelosi P, Carlesso E, Severgnini P, Aspesi M, Gamberoni C, Antonelli M, Conti G, Chiaranda M, Gattinoni L: Noninvasive positive pressure ventilation delivered by helmet vs standard face mask. Intensive Care Med 2003;29:1671–1679.
28.
Navalesi P, Costa R, Ceriana P, Carlucci A, Prinianakis G, Antonelli M, Conti G, Nava S: Non-invasive ventilation in chronic obstructive pulmonary disease patients: helmet versus facial mask. Intensive Care Med 2007;33:74–81.
29.
Nathan SD, Shlobin OA, Ahmad S, Koch J, Barnett SD, Ad N, Burton N, Leslie K: Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 2008;76:288–294.
30.
Baydur A: Mechanical ventilation in interstitial lung disease: which patients are likely to benefit? Chest 2008;133:1062–1063.
31.
Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, Flaherty KR, Franks TJ, Hansell DM, Hartman TE, Kazerooni EA, Kim DS, Kitaichi M, Koyama T, Martinez FJ, Nagai S, Midthun DE, Müller NL, Nicholson AG, Raghu G, Selman M, Wells A: Idiopathic nonspecific interstitial pneumonia. Report of an American Thoracic Society project. Am J Crit Care Med 2008;177:1338–1347.
32.
Bertolini G, Confalonieri M, Rossi C, Rossi G, Simini B, Gorini M, Corrado A; GiViTI (Gruppo italiano per la Valutazione degli interventi in Terapia Intensiva) Group; Aipo (Associazione Italiana Pneumologi Ospedalieri) Group: Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit. Respir Med 2005;99:894–900.
© 2009 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2009
You do not currently have access to this content.